CARDIOME PHARMA Up 20% (CRME)

CARDIOME PHARMA CORP CRME shares are soaring today, gaining more than 20% on nearly three times its average daily volume. The company was upgraded by RBC this morning, so this is helping add to the gains. At last check, shares of CARDIOME PHARMA were up 94 cents to $5.35, a gain of 22% on nearly 1 million shares. Cardiome Pharma Corp., a life sciences company, focuses on developing drugs to treat or prevent cardiovascular diseases.